Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v10-EN
Language French English
Date Updated 2018-12-19 2018-12-19
Drug Identification Number 02373912 02373912
Brand name JAMP-INDAPAMIDE JAMP-INDAPAMIDE
Common or Proper name Indapamide Indapamide
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients INDAPAMIDE INDAPAMIDE
Strength(s) 2.5MG 2.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C03BA C03BA
ATC description LOW-CEILING DIURETICS, EXCL THIAZIDES LOW-CEILING DIURETICS, EXCL THIAZIDES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2016-09-15 2016-09-15
Estimated end date 2020-12-31 2020-12-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments supply issue supply issue
Health Canada comments